GlassScriptPhysician profile
Sasha Melendy
NPI 1740366848
$1,243.39
in general payments reported to CMS, 2019-2025
21 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $48.13 · 2021: $101 · 2022: $471 · 2023: $144 · 2024: $82.67 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $300.12 | 2019-2025 | |
| Gynesonics, INC. | $176.38 | 2022 | |
| Astellas Pharma US INC | $101.81 | 2023-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $83.06 | 2020-2023 | |
| Exact Sciences Corporation | $73.59 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Therapeuticsmd, INC. | $65.92 | 2019-2022 | |
| Coopersurgical, INC. | $52.65 | 2022 | |
| Hologic Sales and Service, LLC | $51.54 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $45.32 | 2021-2022 | |
| Ethicon US, LLC | $43.78 | 2022-2025 | Ethicon, Stratafix, Dermabond Prineo |
| Mallinckrodt Enterprises LLC | $34.96 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $34.62 | 2025 | |
| Mayne Pharma Commercial LLC | $27.34 | 2025 | |
| Baxter Healthcare | $24.81 | 2025 | Perclot |
| Myovant Sciences INC. | $23.09 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $21.13 | 2024 | Myfembree |
| Biogen, INC. | $19.60 | 2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $19.17 | 2019 | |
| Evofem Biosciences, INC. | $16.51 | 2025 | Solosec, Phexx, Phexxi |
| Novo Nordisk INC | $14.36 | 2022 | |
| Amag Pharmaceuticals, INC. | $13.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sasha Melendy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.